This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1982;5(2):127-46.

doi: 10.1007/BF00199792.

Human tumor-associated antigens identified by monoclonal antibodies

K E Hellström, I Hellström, J P Brown

PMID: 6183764
DOI: 10.1007/BF00199792

Review

Human tumor-associated antigens identified by monoclonal antibodies

K E Hellström et al. Springer Semin Immunopathol. 1982.

. 1982;5(2):127-46.

doi: 10.1007/BF00199792.

Authors

K E Hellström, I Hellström, J P Brown

PMID: 6183764
DOI: 10.1007/BF00199792

No abstract available

PubMed Disclaimer

Similar articles

Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
Fink LM, Clarke SM. Fink LM, et al. Prog Clin Pathol. 1984;9:121-33. Prog Clin Pathol. 1984. PMID: 6364219 Review. No abstract available.
Human monoclonal antibody to a neuroectodermal tumor antigen (OFA-I-2).
Katano M, Sidell N, Irie RF. Katano M, et al. Ann N Y Acad Sci. 1983;417:427-34. doi: 10.1111/j.1749-6632.1983.tb32884.x. Ann N Y Acad Sci. 1983. PMID: 6584083
[Monoclonal antibodies in the radionuclide diagnosis and therapy of tumors].
Anokhin IuN, Dedenkov AN, Norets TA. Anokhin IuN, et al. Med Radiol (Mosk). 1985 Jun;30(6):72-8. Med Radiol (Mosk). 1985. PMID: 3894856 Review. Russian. No abstract available.
Human melanoma-associated antigens identified with monoclonal antibodies.
Wilson BS, Giacomini P, Imai K, Natali PG, Nakanishi T, Ruberto G, Ferrone S. Wilson BS, et al. Ric Clin Lab. 1982 Oct-Dec;12(4):517-38. doi: 10.1007/BF02909339. Ric Clin Lab. 1982. PMID: 6760354 Review.
CEA-related antigens: molecular biology and clinical significance.
Shively JE, Beatty JD. Shively JE, et al. Crit Rev Oncol Hematol. 1985;2(4):355-99. doi: 10.1016/s1040-8428(85)80008-1. Crit Rev Oncol Hematol. 1985. PMID: 3886178 Review. No abstract available.

See all similar articles

Cited by

Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide.
Kerr DE, Senter PD, Burnett WV, Hirschberg DL, Hellström I, Hellström KE. Kerr DE, et al. Cancer Immunol Immunother. 1990;31(4):202-6. doi: 10.1007/BF01789169. Cancer Immunol Immunother. 1990. PMID: 2116231 Free PMC article.
Stimulation of peripheral blood lymphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinomas.
Koldovsky P, Koldovsky U, Ebbers J, Vosteen KH. Koldovsky P, et al. Arch Otorhinolaryngol. 1986;243(5):309-12. doi: 10.1007/BF00460207. Arch Otorhinolaryngol. 1986. PMID: 3813967
Manipulation of host resistance in cancer therapy.
Baldwin RW. Baldwin RW. Springer Semin Immunopathol. 1982;5(2):113-25. doi: 10.1007/BF00199791. Springer Semin Immunopathol. 1982. PMID: 6755781 Review. No abstract available.
Imaging mass spectrometry for the precise design of antibody-drug conjugates.
Fujiwara Y, Furuta M, Manabe S, Koga Y, Yasunaga M, Matsumura Y. Fujiwara Y, et al. Sci Rep. 2016 Apr 21;6:24954. doi: 10.1038/srep24954. Sci Rep. 2016. PMID: 27098163 Free PMC article.
The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.
Grimm EA, Vose BM, Chu EW, Wilson DJ, Lotze MT, Rayner AA, Rosenberg SA. Grimm EA, et al. Cancer Immunol Immunother. 1984;17(2):83-9. doi: 10.1007/BF00200041. Cancer Immunol Immunother. 1984. PMID: 6205746 Free PMC article.

See all "Cited by" articles

References

1. Nature. 1981 May 21;291(5812):233-5 - PubMed
1. Int J Cancer. 1982 Feb 15;29(2):175-80 - PubMed
1. Cancer Res. 1981 Nov;41(11 Pt 2):4794-801 - PubMed
1. Cancer Res. 1981 Nov;41(11 Pt 2):4752-66 - PubMed
1. Cancer Res. 1980 Jul;40(7):2523-8 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions

Grants and funding

etc